spacer
home > events calendar
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR
   
  
EVENTS FOR 2017
   
 
EVENTS FOR ALL MAGAZINES
 
     

12th annual Cold Chain Distribution Conference and Exhibition

13-14 December 2017
Copthorne Tara Hotel, London, UK

Responding to the evolution within the industry, SMi is proud to announce the return of its leading 12th annual Cold Chain Distribution event. Returning to London in December, this year's event will remain at the forefront of innovation More>>

 
phone Tel: +44 (0) 207 827 6012
email events@smi-online.co.uk
web www.coldchain-distribution.com/samedan
email Copthorne Tara Hotel, London, UK
 

ManuPharma 2017

6-7 December 2017
Steigenberger Frankfurter Hof, Frankfurt

Europe's first peer-led pharma event for Heads of Tech Ops, Heads of Manufacturing Ops and Site Leads. More>>

 
phone +44 (0) 207 3689857
email Emily.Appleby@wbr.co.uk
web bit.ly/2wrsLdB
email Steigenberger Frankfurter Hof, Frankfurt
 

Cell Therapy Manufacturing & Gene Therapy Congress

6-7 December 2017
RAI, Amsterdam

Bringing together 300+ leaders and key influencers from pharma and biotech companies on 6 - 7 December 2017 in Amsterdam, Cell Therapy Manufacturing & Gene Therapy Congress will provide you with the latest advice for driving manufacturing and commercialisation through direct access to transforming innovative research to prosperous cell & gene manufacturing. More>>

 
phone +44 (0) 20 3377 3903
email LS.Registrations@Knect365.com
web https://lifesciences.knect365.com/celltherapy/?vip_code=CQ3567EBR
email RAI, Amsterdam
 

2nd Annual Clinical Trial Supply East Asia

6-7 December 2017
Seoul, South Korea

This is the only event focusing Clinical Trials Supply in Korea. This event focuses on providing discussions to achieve efficient and seamless clinical supply for trials, as well as providing an In-depth overview into the key regulatory challenges faced by companies in the East Asia region. This is a unique event encompassing discussions around strategies to ensure smooth clinical trial supply chain. More>>

 
phone +44 (0)207 936 6400
email events@arena-international.com
web www.arena-international.com/ctseastasia/
email Seoul, South Korea
 
spacer
Industry Events

10th Annual Pre-Filled Syringes Europe 2018

17-18 January 2018, Copthorne Tara Hotel, Kensington, London UK

Join the calendar event highlight for the medical device industry at Europe's leading 10th annual conference and exhibition on Pre-Filled Syringes when it returns to Central London on 17th and 18th January 2018. Pre-Filled Syringes Europe will once again provide a perfect platform to discuss new advancements and showcase the latest innovations to keep you at the forefront of a dynamic and booming market.
More info >>

Banner of OCT Medical Devices Europe 2018_events_95 on Samedan

White Papers

Modifying MDI Canister Surfaces to Improve Drug Stability & Drug Delivery

Presspart Manufacturing Ltd

Hydrofluoroalkane (HFA)-based propellants are widely used in modern metered-dose inhalers (MDIs), due to their lack hazardous and environmentally-damaging effects. However, an HFA's active pharmaceutical ingredient can interact with the canister substrate, causing deposition of the drug to the canister walls, or interact with the solution, causing degradation and resulting in increased impurity levels. Over the past few years, a number of surface coatings have been developed that can be applied to MDI canisters and valve components, to protect the contents from deposition and degradation. More recently, plasma processes have been developed to modify and improve the surface energy performance of a MDI canister. This approach has a number of advantages to alternative coatings but requires careful optimisation to ensure the highest quality finish and MDI performance. Richard Turner, Business Development Director, Presspart Manufacturing Ltd, explains.
More info >>


News and Press Releases

Synpromics Announces Gene Therapy Research Partnership with Solid Biosciences

Edinburgh, UK September 20th, 2017 - Synpromics Ltd, the leader in gene control, today announces a new research partnership with Solid Biosciences, LLC. Under the terms of the agreement, Synpromics will provide Solid Biosciences access to a set of key muscle-selective promoter candidates to be used in the development of new treatment options for Duchenne muscular dystrophy (DMD).
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement